TGR5 modulators and methods of use thereof

Details for Australian Patent Application No. 2009316484 (hide)

Owner Intercept Pharmaceuticals, Inc.

Inventors Pellicciari, Roberto

Agent Cullens

Pub. Number AU-A-2009316484

PCT Pub. Number WO2010/059859

Priority 08169460.6 19.11.08 EP

Filing date 19 November 2009

Wipo publication date 27 May 2010

International Classifications

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059859 Priority application(s): WO2010/059859

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316485-Intramedullary repair system for bone fractures

2009316483-Method and apparatus for locating and tracking objects in a mining environment